Skip to main content
OpenTrials
Completed

NCT Number: NCT01040156

Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Systemic Aspergillosis Systemic Candidiasis

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Children's Hospital

Tübingen, 72076, Germany

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric patients under the age of 18 years
  • Pediatric patients after HSCT treated with caspofungin
  • Pediatric patients after HSCT treated with liposomal amphotericin

Exclusion criteria

  • Pediatric patients with uncontrolled hematological malignancies
  • Pediatric patients with IFI at start of HSCT

Sponsors and collaborators

Lead sponsor

University Children's Hospital Tuebingen

Other

Registry information

Official study title

Safety, Feasibility and Efficacy of Caspofungin Versus Liposomal Amphotericin B as Antifungal Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients - a Retrospective Phase I/II Study

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Dec 29, 2009
Registry last updated
Dec 29, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.